Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options
A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia